Michael Eamon Peter O'DWYER

City:

Galway

Country:

Ireland

Published Applications:

Last publication date:

2023-07-06

Top Assignees for applications by Michael Eamon Peter O'DWYER

The entities that hold a legal rights for patent applications filed by inventor O'DWYER Michael Eamon Peter:

ONK Therapeutics Limited 3 Galway, Ireland
Onkimmune Limited 2 Donegal Town, Ireland
ONKIMMUNE LIMITED 1 Co. Galway, Ireland

Recent patent applications by O'DWYER Michael Eamon Peter

Michael Eamon Peter O'DWYER from Galway, IE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-07-06

US20230210903A1

Human necessities

HYPOXIA-RESISTANT NATURAL KILLER CELLS

#2 | 2023-01-19

US20230019381A1

Human necessities

NK CELL-BASED THERAPY

#3 | 2022-05-12

US20220143089A1

Human necessities

MODIFIED IMMUNE EFFECTOR CELLS WITH INCREASED RESISTANCE TO CELL DEATH

#4 | 2021-07-29

US20210230241A1

Chemistry; metallurgy

MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES HAVING INCREASED CYTOTOXICITY

#5 | 2021-02-18

US20210046118A1

Human necessities

ENGINEERED NATURAL KILLER CELLS AND USES THEREOF

#6 | 2020-12-17

US20200392458A1

Chemistry; metallurgy

MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES TARGETTING TUMOUR CELLS

#7 | 2019-10-24

US20190321402A1

Human necessities

NK CELLS FOR USE WITH ANITBODIES IN CANCER THERAPY

#8 | 2018-12-06

US20180344768A1

Human necessities

NK CELL-BASED THERAPY

#9 | 2018-07-19

US20180201661A1

Chemistry; metallurgy

Modified natural killer cells and natural killer cell lines having increased cytotoxicity

#10 | 2018-06-14

US20180161371A1

Human necessities

Method of treating multiple myeloma using natural killer cells expressing a chimeric antigen receptor for CD38

InventorID:

2211824 ⎘